grant

Modeling the dynamics of disease elimination

Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 Sept 2022Deadline 31 Jul 2027
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoVAddressAntibiotic AgentsAntibiotic DrugsAntibioticsAreaCOVID-19 virusCOVID19 virusCoV-2CoV2Communicable Disease Contact TracingCommunicable DiseasesCommunitiesCommunity HealthCompensationComputer ModelsComputerized ModelsContact TracingDataData BasesDatabasesDiseaseDisorderDrug resistanceDrugsEndemic DiseasesEpidemiologyEventGoalsHeterogeneityIndividualInfectionInfectious Disease Contact TracingInfectious DiseasesInfectious DisorderInterventionMRSAMath ModelsMeasurementMedicationMethicillin Resistant S. AureusMiscellaneous AntibioticModelingMonitorPatternPerformancePersonsPharmaceutical PreparationsPopulationPredispositionProcessPublic HealthSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2ScanningSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome related corona virus 2SiteStructureSusceptibilityTechniquesTestingTrachomaTransmissionTreatment EfficacyVaccinationWuhan coronavirusaccept vaccinationaccept vaccineburden of diseaseburden of illnesscommunicable disease transmissioncommunity-based healthcomputational modelingcomputational modelscomputer based modelscomputerized modelingcoronavirus disease 2019 viruscoronavirus disease-19 virusdata basedata integrationdesigndesigningdisease burdendisease modeldisease transmissiondisorder modeldrug resistantdrug/agentepidemiologicepidemiologicalhCoV19improvedin silicoinfectious disease transmissionintervention efficacymathematic modelmathematical modelmathematical modelingmethicillin resistance Staphylococcus aureusmethicillin resistant Staphylococcus aureusmethicillin resistant strains of Staphylococcus aureusnCoV2neglected tropical diseasespathogenprogramsresistance to Drugresistant to Drugsimulationstatisticstherapeutic efficacytherapy efficacytooltransmission processvaccination acceptabilityvaccination acceptancevaccination confidencevaccination uptakevaccination willingnessvaccine acceptabilityvaccine acceptancevaccine confidencevaccine uptakevaccine willingness
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Elimination of an infectious disease is often a goal of the public health community. Although that goal is rarely
achieved, the tremendous expansion of epidemiological databases provides new opportunities to test

hypotheses concerning elimination with mathematical modeling. Besides improving our scientific

understanding of disease transmission, hypotheses validated through mathematical modeling provide public

health practitioners with a more structured, quantitative assessment of how elimination of specific pathogens

can be achieved. This proposal aims to develop an interconnected set of modeling tools to support elimination

of communicable diseases. A variety of processes used to achieve disease elimination will be considered

including use of mass drug administration to eliminate neglected tropical diseases such as trachoma,

vaccination for preventable diseases such as SARS-CoV-2, and antibiotic stewardship efforts to curtail drug

resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA). A key theme is the

requirement of subcritical transmission for disease elimination, meaning that the average number of new

infections each case causes is less than one. A major goal is to elucidate the transmission dynamics of

subcritical diseases on the brink of elimination. Transmission heterogeneity may arise from many

mechanisms including super-shedding of certain individuals, pockets of susceptibility such as in a community

with low vaccine uptake, and contact structure in which some individuals have the potential to infect many

others. Simulations of various patterns of disease transmission will be used to develop distinct measurements

of transmission heterogeneity. In addition, new techniques to infer and compensate for observation error will be

developed that integrate data on the observation process, such as the proportion of cases identified

retrospectively via contact tracing programs. Models of transmission dynamics will be used to identify

transmission-hotspots and superspreaders that can jeopardize elimination. People, areas, or events that

have increased transmission potential can maintain endemic disease transmission even though the population-

level average value of R may be less than one. In the first stage of this objective, we will use existing models to

construct a suite of in silico simulations to compare the performance of various scan statistics designed to

detect disease burden beyond what is expected by chance. In the second stage, we will apply these scan

statistics to observational data. Identification of transmission-hotspots and supersreaders permits optimization

of disease elimination strategies. To eliminate disease, it is insufficient to merely identify transmission-

hotspots or superspreading activity. A strategy is needed for suppressing the sites, events, or people that

cause higher levels of transmission. We will use mathematical and computational models for disease

elimination to address 1) the impact of control interventions, 2) the optimal distribution of a limited treatment

supply, and 3) monitoring of treatment efficacy.

Grant Number: 5R35GM147702-04
NIH Institute/Center: NIH

Principal Investigator: Seth Blumberg

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →